Cargando…
Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrat...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930590/ https://www.ncbi.nlm.nih.gov/pubmed/24586164 http://dx.doi.org/10.1371/journal.ppat.1003960 |
_version_ | 1782304551168114688 |
---|---|
author | van Gent, Michiel Braem, Steven G. E. de Jong, Annemieke Delagic, Nezira Peeters, Janneke G. C. Boer, Ingrid G. J. Moynagh, Paul N. Kremmer, Elisabeth Wiertz, Emmanuel J. Ovaa, Huib Griffin, Bryan D. Ressing, Maaike E. |
author_facet | van Gent, Michiel Braem, Steven G. E. de Jong, Annemieke Delagic, Nezira Peeters, Janneke G. C. Boer, Ingrid G. J. Moynagh, Paul N. Kremmer, Elisabeth Wiertz, Emmanuel J. Ovaa, Huib Griffin, Bryan D. Ressing, Maaike E. |
author_sort | van Gent, Michiel |
collection | PubMed |
description | Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts. |
format | Online Article Text |
id | pubmed-3930590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39305902014-02-25 Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling van Gent, Michiel Braem, Steven G. E. de Jong, Annemieke Delagic, Nezira Peeters, Janneke G. C. Boer, Ingrid G. J. Moynagh, Paul N. Kremmer, Elisabeth Wiertz, Emmanuel J. Ovaa, Huib Griffin, Bryan D. Ressing, Maaike E. PLoS Pathog Research Article Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts. Public Library of Science 2014-02-20 /pmc/articles/PMC3930590/ /pubmed/24586164 http://dx.doi.org/10.1371/journal.ppat.1003960 Text en © 2014 van Gent et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article van Gent, Michiel Braem, Steven G. E. de Jong, Annemieke Delagic, Nezira Peeters, Janneke G. C. Boer, Ingrid G. J. Moynagh, Paul N. Kremmer, Elisabeth Wiertz, Emmanuel J. Ovaa, Huib Griffin, Bryan D. Ressing, Maaike E. Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling |
title | Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling |
title_full | Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling |
title_fullStr | Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling |
title_full_unstemmed | Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling |
title_short | Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling |
title_sort | epstein-barr virus large tegument protein bplf1 contributes to innate immune evasion through interference with toll-like receptor signaling |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930590/ https://www.ncbi.nlm.nih.gov/pubmed/24586164 http://dx.doi.org/10.1371/journal.ppat.1003960 |
work_keys_str_mv | AT vangentmichiel epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT braemstevenge epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT dejongannemieke epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT delagicnezira epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT peetersjannekegc epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT boeringridgj epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT moynaghpauln epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT kremmerelisabeth epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT wiertzemmanuelj epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT ovaahuib epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT griffinbryand epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling AT ressingmaaikee epsteinbarrviruslargetegumentproteinbplf1contributestoinnateimmuneevasionthroughinterferencewithtolllikereceptorsignaling |